Marketed under the trade name Exelon, a parasympathomimetic or cholinergic agent in treatment of mild to moderate Alzheimer's-type dementia and Parkinson's-type dementia. Administered orally, or with a transdermal patch which reduces side effects which typically include nausea and vomiting.